Opinion

Video

Metastatic Prostate Cancer: Background and Patient Prognosis

An expert provides an overview of metastatic prostate cancer, including information on how it advances, patient prognosis, and what factors influence outcomes.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
      Related Videos
      Man talking with a doctor | Image Credit: © Pcess609 - stock.adobe.com
      Expert discusses the relationship between RCTs and real-world efficacy of prostate cancer treatments
      1 expert in this video
      Clinical Benefits of BPH Treatments
      Study data point to gender disparities in oncology research citations
      Study data point to gender disparities in oncology research citations
      Nitin Yerram, MD, highlights trial of 177Lu-PSMA-617 in localized prostate cancer
      Nitin Yerram, MD, highlights trial of 177Lu-PSMA-617 in localized prostate cancer
      1 expert in this video
      BPH Management: Patient Outcome Evolution
      Neeraj Agarwal, MD, shares key takeaways from TALAPRO-2
      Neeraj Agarwal, MD, shares key takeaways from TALAPRO-2
      Final Thoughts and Clinical Trials in NMIBC
      Final Thoughts and Clinical Trials in NMIBC
      Uptake of New Treatments in Urology Practice
      Uptake of New Treatments in Urology Practice
      Patient Communication and Treatment Adherence in NMIBC
      Patient Communication and Treatment Adherence in NMIBC
      1 expert in this video
      Resective Surgery and Minimally Invasive Procedures For BPH
      Related Content
      Conceptual image for prostate cancer treatment, 3D illustration showing destruction of a tumor inside prostate gland | Image Credit: @ Dr_Microbe - stock.adobe.com
      May 2nd 2025

      Phase 3 trial of capivasertib in mCRPC discontinued following IDMC recommendation

      Hannah Clarke
      The committee determined that the study was unlikely to meet its dual primary end points of radiographic progression-free survival and overall survival.
      Pearls & Perspectives: Evolving role of APPs in urology, with Corinna Hughes, DNP, at AUA 2025
      May 1st 2025

      Pearls & Perspectives: Evolving role of APPs in urology, with Corinna Hughes, DNP, at AUA 2025

      Amy M. Pearlman, MD
      Corinna Hughes, DNP, sits down with Amy Pearlman, MD, to discuss the evolving recognition of APPs in urology.
      ARANOTE substudy highlights benefits of darolutamide in Black men
      April 28th 2025

      ARANOTE substudy highlights benefits of darolutamide in Black men

      Benjamin P. Saylor
      The investigators reported that treatment with darolutamide reduced the risk of radiological progression or death by 49% in Black men.
      Pearls & Perspectives: Future of reconstructive urology, with Ryan Terlecki, MD, at AUA 2025
      April 30th 2025

      Pearls & Perspectives: Future of reconstructive urology, with Ryan Terlecki, MD, at AUA 2025

      Amy M. Pearlman, MD Ryan Terlecki, MD
      A discussion on evolution of surgical education, importance of video training, and the future of patient-centered care in reconstruction.
      Stephen J. Freedland, MD
      April 28th 2025

      Most men in EMBARK trial recover T levels following treatment suspension

      Benjamin P. Saylor
      More than 80% of patients in both groups had a full recovery of testosterone.
      Du Geon Moon, MD, PhD | Credit: Korea University College of Medicine
      April 27th 2025

      Sildenafil/Clomipramine Combo Boosts Outcomes in Premature Ejaculation

      Patrick Campbell
      A phase 3 trial reveals a combination therapy for premature ejaculation significantly enhances treatment outcomes.
      © 2025 MJH Life Sciences

      All rights reserved.